Related Experiment Video
Updated: Oct 23, 2025
08:33
A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
Published on: December 15, 2014
11.9K
Propofol Ameliorates Exaggerated Human Neutrophil Activation in a LPS Sepsis Model
Andre Bredthauer1,2, Angela Geiger1, Michael Gruber1
1Department of Anesthesiology, University Medical Center Regensburg, Regensburg, Germany.
Journal of Inflammation Research
|August 19, 2021
Summary
Propofol may improve immune function in sepsis by modulating polymorphonuclear granulocyte (PMN) activity. This study found propofol ameliorated excessive PMN responses in an ex vivo sepsis model, suggesting potential benefits for septic patients.
Area of Science:
- Immunology
- Pharmacology
- Critical Care Medicine
Background:
- Sepsis is a major global health concern, frequently requiring intensive care and mechanical ventilation.
- Propofol, a common anesthetic, is known to interact with polymorphonuclear granulocytes (PMNs), key immune cells.
Purpose of the Study:
- To investigate propofol's effects on PMN functions during experimental Gram-negative sepsis.
- To determine if propofol influences PMN migration, reactive oxygen species (ROS) production, and NETosis.
Main Methods:
- Human PMNs were isolated and exposed to varying concentrations of propofol and lipopolysaccharide (LPS).
- Live cell imaging assessed PMN migration, ROS production, and NETosis.
- Flow cytometry analyzed cell viability and antigen expression.
Main Results:
- Propofol significantly reduced PMN migration speed and track length in LPS-induced sepsis.
- Propofol accelerated NETosis and ROS production in non-septic conditions, indicating enhanced immune function.
- Propofol mitigated the exaggerated NETosis and ROS production caused by LPS.
Conclusions:
- Propofol demonstrates a beneficial effect by improving exaggerated PMN activation in an ex vivo sepsis model.
- Further research is needed to confirm these potential immune-restoring benefits in septic patients.
